AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,219,000 | +1150.6% | 939,811 | +519.7% | 0.00% | – |
| Q2 2022 | $1,137,000 | -54.3% | 151,661 | -44.5% | 0.00% | -100.0% |
| Q1 2022 | $2,488,000 | +56.1% | 273,428 | +20.5% | 0.00% | – |
| Q4 2021 | $1,594,000 | -34.9% | 226,930 | +5.7% | 0.00% | -100.0% |
| Q3 2021 | $2,447,000 | -34.4% | 214,675 | -7.9% | 0.00% | 0.0% |
| Q2 2021 | $3,732,000 | -4.7% | 233,090 | +6.4% | 0.00% | 0.0% |
| Q1 2021 | $3,916,000 | +12.8% | 219,121 | -14.7% | 0.00% | 0.0% |
| Q4 2020 | $3,471,000 | -75.2% | 256,929 | -78.4% | 0.00% | -75.0% |
| Q3 2020 | $14,000,000 | +87.5% | 1,189,526 | +135.2% | 0.00% | +100.0% |
| Q2 2020 | $7,465,000 | +189.5% | 505,753 | +164.7% | 0.00% | +100.0% |
| Q1 2020 | $2,579,000 | +16.5% | 191,062 | +108.6% | 0.00% | 0.0% |
| Q4 2019 | $2,214,000 | -74.4% | 91,596 | -79.6% | 0.00% | -50.0% |
| Q3 2019 | $8,632,000 | -10.7% | 449,135 | +37.3% | 0.00% | -33.3% |
| Q2 2019 | $9,665,000 | +20.8% | 327,053 | +94.1% | 0.00% | +50.0% |
| Q1 2019 | $8,002,000 | +132.5% | 168,459 | +76.7% | 0.00% | +100.0% |
| Q4 2018 | $3,441,000 | -47.7% | 95,338 | -10.8% | 0.00% | -50.0% |
| Q3 2018 | $6,578,000 | +1.1% | 106,873 | +11.0% | 0.00% | 0.0% |
| Q2 2018 | $6,504,000 | -28.4% | 96,287 | -42.5% | 0.00% | 0.0% |
| Q1 2018 | $9,081,000 | -3.8% | 167,392 | +6.0% | 0.00% | 0.0% |
| Q4 2017 | $9,439,000 | +16.1% | 157,977 | -5.5% | 0.00% | 0.0% |
| Q3 2017 | $8,128,000 | -24.5% | 167,229 | -18.4% | 0.00% | -33.3% |
| Q2 2017 | $10,763,000 | +6.4% | 204,829 | -8.2% | 0.00% | 0.0% |
| Q1 2017 | $10,115,000 | +54.0% | 223,053 | +28.5% | 0.00% | +50.0% |
| Q4 2016 | $6,570,000 | -43.4% | 173,580 | -43.6% | 0.00% | -50.0% |
| Q3 2016 | $11,618,000 | +44.8% | 307,842 | -32.5% | 0.00% | +33.3% |
| Q2 2016 | $8,024,000 | +26.8% | 455,942 | -12.4% | 0.00% | +50.0% |
| Q1 2016 | $6,327,000 | +309.5% | 520,361 | +720.1% | 0.00% | – |
| Q4 2015 | $1,545,000 | -31.1% | 63,449 | -49.8% | 0.00% | – |
| Q3 2015 | $2,244,000 | -55.3% | 126,517 | -55.5% | 0.00% | -100.0% |
| Q2 2015 | $5,016,000 | -51.1% | 284,149 | -13.3% | 0.00% | -33.3% |
| Q1 2015 | $10,268,000 | +32.0% | 327,620 | +23.0% | 0.00% | +50.0% |
| Q4 2014 | $7,776,000 | -23.0% | 266,387 | -45.4% | 0.00% | -33.3% |
| Q3 2014 | $10,104,000 | +31.8% | 488,329 | +57.8% | 0.00% | +50.0% |
| Q2 2014 | $7,664,000 | – | 309,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|